+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Active Implantable Medical Devices Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2017-2025

  • ID: 4851419
  • Report
  • Region: Global
  • 182 pages
  • Transparency Market Research
1 of 2

Global Active Implantable Medical Devices Market: Overview

Active Implantable Medical Devices are medical implantable devices like cochlear implants, implantable defibrillators, Implantable cardiac monitoring devices, implantable nerve stimulators, ventricular assist devices (VAD) and implantable cardiac pacemakers primarily used to detect, monitor, avert, alleviate or treat disease or conditions in the patients. This report analyzes the current and future prospects of the active implantable medical devices market based on product, procedure, end user and geography.  

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of active implantable devices used in medical procedures in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases.

Global Active Implantable Medical Devices Market: Scope of the Study

The report provides estimated market size in terms of US$ Mn for product, procedure, end user, and geography for the period 2016 to 2025. The revenue generated from product type was calculated by considering the adoption rate of active medical implants across all geographies, number of product launched, average cost of products, trends in industry, and end user trends, among others. It comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market.

It also provides information and data analysis of the market with respect to market segments based on product, procedure, end user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the active implantable medical devices market in the current and future scenario. The report also provides Porter’s five force analysis that studies five factors and their impact on the active implantable medical devices market.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the active implantable medical devices market.

Companies Mentioned in the Report

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the active implantable medical devices market include Boston Scientific Corporation, Medtronic Plc., Abbott Laboratories, Sonova Holding AG, BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Ltd., Nurotron Biotechnology Co. Ltd., William Demant Holding A/S and MED-EL Medical Electronics. Collaboration agreements was the primary strategy adopted by the major market players to enter into the active implantable medical devices.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Active Implantable Medical Devices Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Active Implantable Medical Devices Market Analysis and Forecasts, 2017-2025
4.5. Porter’s Five Force Analysis
4.6. Market Outlook

5. Global Active Implantable Medical Devices Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings/Developments
5.3. Key Trends
5.4. Market Value Forecast By Product
5.4.1. Cardiac Pacemaker
5.4.1.1. Single Chamber Pacemaker
5.4.1.2. Dual Chamber Pacemaker
5.4.1.3. Others
5.4.2. Implantable Cardioverter Defibrillators (ICD)
5.4.2.1. Transvenous Implantable Cardioverter Defibrillators
5.4.2.2. Subcutaneous Implantable Cardioverter Defibrillators
5.4.3. Nerve Stimulators
5.4.4. Cochlear Implants
5.4.5. Ventricular Assist Devices (VAD)
5.4.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
5.5. Market Attractiveness By Product

6. Global Active Implantable Medical Devices Market Analysis and Forecasts, By Procedure
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Key Trends
6.4. Market Value Forecast By Procedure
6.4.1. Cardiovascular Implants
6.4.2. Neurological Implants
6.4.3. Hearing Implants
6.4.4. Others
6.5. Market Attractiveness By Procedure

7. Global Active Implantable Medical Devices Market Analysis and Forecasts, By End-User
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Key Trends
7.4. Market Value Forecast By End-User
7.4.1. Hospitals
7.4.2. Ambulatory Surgery Centers
7.4.3. Specialty Clinics
7.5. Market Attractiveness By End-User

8. Global Active Implantable Medical Devices Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East and Africa
8.3. Market Attractiveness By Country/Region

9.North America Active Implantable Medical Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Key Trends
9.2. Market Value Forecast By Product
9.2.1. Cardiac Pacemaker
9.2.1.1. Single Chamber Pacemaker
9.2.1.2. Dual Chamber Pacemaker
9.2.1.3. Others
9.2.2. Implantable Cardioverter Defibrillators (ICD)
9.2.2.1. Transvenous Implantable Cardioverter Defibrillators
9.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
9.2.3. Nerve Stimulators
9.2.4. Cochlear Implants
9.2.5. Ventricular Assist Devices (VAD)
9.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
9.3. Market Value Forecast By Procedure
9.3.1. Cardiovascular Implants
9.3.2. Neurological Implants
9.3.3. Hearing Implants
9.3.3. Others
9.4. Market Value Forecast By End-User
9.4.1. Hospitals
9.4.2. Ambulatory Surgery Centers
9.4.3. Specialty Clinics
9.5. Market Value Forecast By Country
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis

10. Europe Active Implantable Medical Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Key Trends
10.2. Market Value Forecast By Product
10.2.1. Cardiac Pacemaker
10.2.1.1. Single Chamber Pacemaker
10.2.1.2. Dual Chamber Pacemaker
10.2.1.3. Others
10.2.2. Implantable Cardioverter Defibrillators (ICD)
10.2.2.1. Transvenous Implantable Cardioverter Defibrillators
10.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
10.2.3. Nerve Stimulators
10.2.4. Cochlear Implants
10.2.5. Ventricular Assist Devices (VAD)
10.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
10.3. Market Value Forecast By Procedure
10.3.1 Cardiovascular Implants
10.3.2.Neurological Implants
10.3.3.Hearing Implants
10.3.4.Others
10.4. Market Value Forecast By End-User , 2015-2025
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Specialty Clinics
10.5. Market Value Forecast By Country , 2015-2025
10.5.1. Germany
10.5.2. France
10.5.3. U.K.
10.5.4. Italy
10.5.4. Spain
10.5.4. Rest of Europe
10.6. Market Attractiveness Analysis

11. Asia Pacific Active Implantable Medical Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Key Trends
11.2. Market Value Forecast By Product
11.2.1. Cardiac Pacemaker
11.2.1.1. Single Chamber Pacemaker
11.2.1.2. Dual Chamber Pacemaker
11.2.1.3. Others
11.2.2. Implantable Cardioverter Defibrillators (ICD)
11.2.2.1. Transvenous Implantable Cardioverter Defibrillators
11.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
11.2.3. Nerve Stimulators
11.2.4. Cochlear Implants
11.2.5. Ventricular Assist Devices (VAD)
11.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
11.3. Market Value Forecast By Procedure
11.3.1 Cardiovascular Implants
11.3.2.Neurological Implants
11.3.3.Hearing Implants
11.3.4.Others
11.4. Market Value Forecast By End-User
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Specialty Clinics
11.5. Market Value Forecast By Country
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Australia
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis

12. Latin America Active Implantable Medical Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Key Trends
12.2. Market Value Forecast By Product
12.2.1. Cardiac Pacemaker
12.2.1.1. Single Chamber Pacemaker
12.2.1.2. Dual Chamber Pacemaker
12.2.1.3. Others
12.2.2. Implantable Cardioverter Defibrillators (ICD)
12.2.2.1. Transvenous Implantable Cardioverter Defibrillators
12.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
12.2.3. Nerve Stimulators
12.2.4. Cochlear Implants
12.2.5. Ventricular Assist Devices (VAD)
12.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
12.3. Market Value Forecast By Procedure
12.3.1 Cardiovascular Implants
12.3.2.Neurological Implants
12.3.3.Hearing Implants
12.3.4.Others
12.4. Market Value Forecast By End-User
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Specialty Clinics
12.5. Market Value Forecast By Country
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis

13. Middle East and Africa Active Implantable Medical Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.2. Key Trends
13.2. Market Value Forecast By Product
13.2.1. Cardiac Pacemaker
13.2.1.1. Single Chamber Pacemaker
13.2.1.2. Dual Chamber Pacemaker
13.2.1.3. Others
13.2.2. Implantable Cardioverter Defibrillators (ICD)
13.2.2.1. Transvenous Implantable Cardioverter Defibrillators
13.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
13.2.3. Nerve Stimulators
13.2.4. Cochlear Implants
13.2.5. Ventricular Assist Devices (VAD)
13.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
13.3. Market Value Forecast By Procedure
13.3.1 Cardiovascular Implants
13.3.2.Neurological Implants
13.3.3.Hearing Implants
13.3.4.Others
13.4. Market Value Forecast By End-User
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Specialty Clinics
13.5. Market Value Forecast By Country
13.5.1. South Africa
13.5.2. Israel
13.5.3. GCC countries
13.5.4. Rest of MEA
13.6. Market Attractiveness Analysis

14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2016)
14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Business Overview
14.3.1.3. Product Portfolio
14.3.1.4. Financial Overview
14.3.1.5. SWOT Analysis
14.3.1.6. Strategic overview
14.3.2. BIOTRONIK SE & Co. KG
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Business Overview
14.3.2.3. Product Portfolio
14.3.2.4. Financial Overview
14.3.2.5. SWOT Analysis
14.3.2.6. Strategic overview
14.3.3. Boston Scientific Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Business Overview
14.3.3.3. Product Portfolio
14.3.3.4. Financial Overview
14.3.3.5. SWOT Analysis
14.3.3.6. Strategic overview
14.3.4. Cochlear Ltd
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Business Overview
14.3.4.3. Product Portfolio
14.3.4.4. Financial Overview
14.3.4.5. SWOT Analysis
14.3.4.6. Strategic overview
14.3.5. Sonova Holding AG
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Business Overview
14.3.5.3. Product Portfolio
14.3.5.4. Financial Overview
14.3.5.5. SWOT Analysis
14.3.5.6. Strategic overview
14.3.6. LivaNova PLC
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Business Overview
14.3.6.3. Product Portfolio
14.3.6.4. Financial Overview
14.3.6.5. SWOT Analysis
14.3.6.6. Strategic overview
14.3.7. Medtronic Plc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Business Overview
14.3.7.3. Product Portfolio
14.3.7.4. Financial Overview
14.3.7.5. SWOT Analysis
14.3.7.6. Strategic overview
14.3.8. MED-EL Medical Electronics
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Business Overview
14.3.8.3. Product Portfolio
14.3.8.4. Financial Overview
14.3.8.5. SWOT Analysis
14.3.8.6. Strategic overview
14.3.9. Nurotron Biotechnology Co. Ltd
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Business Overview
14.3.9.3. Product Portfolio
14.3.9.4. Financial Overview
14.3.9.5. SWOT Analysis
14.3.9.6. Strategic overview
14.3.10. William Demant Holding A/S
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Business Overview
14.3.10.3. Product Portfolio
14.3.10.4. Financial Overview
14.3.10.5. SWOT Analysis
14.3.10.6. Strategic overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll